Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

50 results about "Assay sensitivity" patented technology

Assay sensitivity is a property of a clinical trial defined as the ability of a trial to distinguish an effective treatment from a less effective or ineffective intervention. Without assay sensitivity, a trial is not internally valid and is not capable of comparing the efficacy of two interventions.

Detection card for quantitatively detecting human total IgE antibody, preparation method, kit and application

The invention belongs to the technical field of immunodiagnosis, and relates to a detection card for quantitatively detecting human total IgE antibodies, which comprises a card shell and a test strip, and the test strip is arranged in the card shell; the test strip comprises a sample pad, a combination pad, a reaction film and an absorption pad which are arranged on a bottom plate, wherein an animal anti-human IgE monoclonal antibody marked by lanthanide fluorescent microspheres is arranged on the combination pad; a detection line coated with an animal anti-human IgE polyclonal antibody and a quality control line coated with an animal IgG antibody are arranged on the reaction film. The invention further provides a preparation method, a kit and application of the detection card for quantitatively detecting the human total IgE antibody. The method can effectively eliminate the interference of non-specific fluorescence, greatly improves the analysis sensitivity, and is simple and convenient to operate and low in cost.
Owner:DAAN GENE CO LTD

Sensitization method for analyzing heavy mass number elements by X-ray fluorescence spectrometry

The invention relates to the technical field of analysis and detection, in particular to a sensibilization method for analyzing heavy mass number elements by X-ray fluorescence spectrometry, which comprises the following steps: placing a sample to be detected in a grinding tank, adding ultrapure water and a grinding medium, and crushing by a circulating ball milling process until a superfine powder sample in a target particle size range is obtained; a large amount of liquid in a sample is rapidly removed by adopting a suction filtration method, the sample is dried in a sterile dust-free drying oven, the dried sample is ground again, and the method is suitable for analysis and detection of Ga, Br, Bi, Pb, Th, U, Ca, Y, Zr and Mo elements. According to the invention, a small amount of sample is processed by using a rapid and simple ultrafine crushing technology, the sample is rapidly crushed to a target particle size range, the problem of low heavy mass number element analysis sensitivity under the small amount of sample is overcome, the signal detection intensity is improved, and the heavy mass number element analysis sensitivity of the X-ray fluorescence spectrometry is effectively improved.
Owner:INST OF GEOPHYSICAL & GEOCHEMICAL EXPLORATION CHINESE ACAD OF GEOLOGICAL SCI

Immunochromatography test strip for enhancing near-infrared two-region fluorescence through supramolecular host-guest interaction and preparation method of immunochromatography test strip

The invention relates to the technical field of clinical medical examination, in particular to an immunochromatography test strip for enhancing near-infrared two-region fluorescence through supramolecular host-guest interaction and a preparation method of the immunochromatography test strip. The invention provides a preparation method of an immunochromatographic test strip. The preparation method comprises the following steps: preparing a rare earth nanoparticle (RENPs) labeling solution; preparing a microsphere combination pad; preparing a sample pad; coating an antibody with a nitrocellulose membrane; and assembling and manufacturing the card. The aggregation phenomenon and partial fluorescence quenching effect caused in the surface modification process of the rare earth microspheres are reduced by utilizing an efficient surface modification strategy of a supramolecular host compound, the fluorescence luminescence property of the rare earth microspheres is effectively improved, and meanwhile, the antibody labeling efficiency of the rare earth microspheres is further improved by utilizing a supramolecular self-assembly strategy; the prepared test strip is obviously improved in analysis sensitivity, has the advantages of simplicity in operation, low cost and short detection time, and is suitable for rapid and sensitive detection of low-concentration markers in complex biological samples.
Owner:YANTAI NEW DRUG DEV SHANDONG PROVINCIAL LAB

Methods and systems for rapid detection of salmonella using infectious agents

To provide methods and systems for rapid detection of Salmonella using infectious agents.SOLUTION: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as Salmonella-specific bacteriophage, allows detection of a specific microorganism, such as Salmonella spp. and an indicator signal may be amplified to optimize assay sensitivity.SELECTED DRAWING: None
Owner:LABORATORY CORPORATION OF AMERICA HOLDINGS INC

Mobile phase continuous liquid adding device for liquid chromatography

A partition plate is arranged in a bottle cavity of the mobile phase continuous liquid adding device and divides the bottle cavity into a main cavity and a liquid supplementing cavity, the partition plate downwards extends to the position about one centimeter away from the bottom of the bottle, and the main cavity and the liquid supplementing cavity are communicated at the bottom of the bottle. A liquid supplementing opening leading to the liquid supplementing cavity is formed in the bottle cap, and a liquid supplementing channel is arranged between the bottle cap and the liquid supplementing cavity. And the supplemented mobile phase flows through the liquid supplementing channel, enters the liquid supplementing cavity and is further supplemented into the main cavity. The supplemented mobile phase and the mobile phase in the liquid supplementing cavity are mixed to generate bubbles, and the bubbles only float upwards in the liquid supplementing cavity, are blocked by the partition plate and cannot flow into the main cavity, so that the mobile phase in the main cavity is not influenced by the bubbles, cannot bring noise to the liquid chromatograph and cannot cause sharp noise peaks of an obtained chromatogram, and the quality of the liquid chromatograph is improved. And the analysis sensitivity of the liquid chromatograph is not reduced. The floating plug is arranged in the liquid supplementing cavity, and the floating plug floats upwards to plug the liquid supplementing channel along with supplementing of the mobile phase, so that the mobile phase in the liquid supplementing cavity is prevented from flowing back and overflowing, and the risk of leakage is avoided.
Owner:GUANGZHOU MEDICAL UNIV

Methods and systems for rapid detection of microorganisms using recombinant bacteriophages

Disclosed herein are methods and systems for rapid detection of microorganisms in a sample without enrichment culture of the microorganisms. Also disclosed is a modified bacteriophage comprising a non-natural indicator gene in the late gene region. The indicator product is not a fusion protein. The specificity of infectious agents allows targeting of specific microorganisms, and the indicator signal can be enlarged to optimize assay sensitivity.
Owner:LABORATORY CORPORATION OF AMERICA HOLDINGS INC

Methods for producing mutant bacteriophages for detection of listeria

To provide methods for producing mutant bacteriophages for detection of LISTERIA.SOLUTION: Methods for the production of mutant bacteriophages with altered host range are disclosed herein. Additionally, methods and systems for rapid detection of microorganisms, such as Listeria spp., in a sample are disclosed herein. A genetically modified bacteriophage comprising an indicator gene in the late gene region is also disclosed. The specificity of the bacteriophage, such as a Listeria-specific bacteriophage, allows detection of a specific microorganism, such as Listeria spp., and an indicator signal may be amplified to optimize assay sensitivity.SELECTED DRAWING: None
Owner:LABORATORY CORPORATION OF AMERICA HOLDINGS INC

Methods and systems for rapid detection of microorganisms using recombinant infectious agents expressing indicator subunits

Disclosed herein are methods and systems for rapidly detecting microorganisms, such as bacteria, in a sample. Also disclosed are genetically modified bacteriophages that contain an indicator gene encoding a subunit of an indicator protein. The specificity of the bacteriophage allows for detection of specific target bacteria and amplifies the indicator signal to optimize assay sensitivity.
Owner:LABORATORY CORPORATION OF AMERICA HOLDINGS INC

Assay of lysosomal storage disease

The present disclosure provides a method of detecting an anti-lysosomal enzyme antibody in a human subject (e.g., in the presence of a circulating lysosomal enzyme) and a method of increasing the efficacy of an anti-lysosomal enzyme antibody assay (e.g., increasing assay sensitivity and circulating lysosomal enzyme tolerance), comprising pre-treating the biological sample of the subject with a base having a pH of about 11 or greater, and measuring the presence of the anti-lysosomal enzyme antibody in the biological sample of the subject.
Owner:SANGAMO THERAPEUTICS INC

Development of DTT-mediated CRISPR / Cas12a system and HPV detection application

The invention relates to the technical field of biological detection, in particular to development of a DTT-mediated CRISPR / Cas12a system and HPV (human papillomavirus) detection application. The DTT-mediated CRISPR / Cas12a system is constructed, the PAM-sequence-free nucleic acid is targeted, the nucleic acid detection range of the CRISPR / Cas12a system is remarkably expanded, and meanwhile the analysis sensitivity and specificity of the CRISPR / Cas12a system are improved.
Owner:CHONGQING MEDICAL UNIVERSITY

Methods and systems for the rapid detection of cronobacter using infectious agents

Disclosed herein are methods and systems for rapid detection of microorganisms such as Cronobacter spp. in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as Cronobacter-specific bacteriophage, allows detection of a specific microorganism, such as Cronobacter spp. and an indicator signal may be amplified to optimize assay sensitivity.
Owner:LABORATORY CORPORATION OF AMERICA HOLDINGS INC

D-dimer detection kit and detection method thereof

The present application relates to the technical field of medical detection, in particular to a D-dimer detection kit and a detection method thereof.The present application provides a D-dimer detection kit, which is composed of reagent R1 and reagent R2.The reagent R1 is mainly composed of a buffer, a preservative, an inorganic salt, a surfactant and a protein stabilizer;the reagent R2 is mainly composed of a buffer, a protein protective agent, sucrose and a preservative.The experiment shows that the kit is easy to operate and has a short analysis time, and the kit also has high analysis sensitivity, optimal precision, good test accuracy and a wide linear range, and can be combined with an automatic analyzer, which is conducive to its wide use in clinical practice.
Owner:AUTOBIO BIOCHEMISTRY CO LTD

Lipidome analysis system based on capillary electrophoresis and its application and lipidome analysis method

The present invention discloses a lipidome analysis system based on capillary electrophoresis, its application and lipidome analysis method, wherein the analysis system comprises a voltage device, a capillary, a photochemical reactor, an ionization interface and a mass spectrometer; the voltage device is electrically connected to the capillary, and the capillary is connected to the mass spectrometer through the ionization interface; the photochemical reactor is arranged on the capillary. Thus, by arranging a photochemical reactor on the capillary, an online photochemical reaction on the capillary can be realized, that is, the system of the present invention can generate a chemical derivatization reaction during the electrophoretic separation process, and through mass spectrometer analysis, the fine structure of lipids can be analyzed; the system of the present invention realizes the analysis of trace samples and direct complex samples while retaining the characteristics of high-throughput photochemical derivatization; in addition, the system of the present invention also has the advantage of high analytical sensitivity.
Owner:TSINGHUA UNIVERSITY

Detection method of intermediate 5-chloroethyl-6-chloroindole-2-ketone for ziprasidone synthesis

The invention provides a detection method of an intermediate 5-chloroethyl-6-chloroindole-2-ketone for ziprasidone synthesis, and belongs to the technical field of drug quality analysis and detection. According to the method, a cyano silane bonded silica gel chromatographic column is selected, acetonitrile in a certain proportion and a phosphate-triethylamine buffer solution with the pH value of 5.0 + / -0.2 are adopted as mobile phases, program gradient elution is cooperatively carried out, a main product can be effectively separated from impurities, and high separation degree and analysis sensitivity are achieved; according to the method, a diode array detector is adopted, and 2008-2022 Shimadzu Corporation LabSolutions software / similar software carried by the diode array detector is used for confirming the maximum absorption wavelength and the relative percentage content of main impurities in the main product 5-chloroethyl-6-chloroindole-2-ketone. The method provided by the invention is short in analysis time, simple in analysis operation, capable of determining whether the main product contains impurities or not, and relatively good in repeatability and adaptability.
Owner:JIANGXI KAIYUAN BIOMEDICAL TECH CO LTD

Method of sequence independent quantification of proteolytically labile plasma lambda free light chain proteins for AL amyloidosis diagnosis

A method for combining restrictive proteolysis and immunoassays to specifically detect and quantify amyloid-genic XFLC in a biological fluid. This method is accomplished by the use of mAbs that enable the detection and quantification of neoepitopes on dLCCD biomarkers produced after restricted proteolysis of ZFLC, which is very advantageous for kinetically unstable or amyloid-genic LFLC. The methods do not depend on FLC primary sequences in variable and constant domains, and can be used to detect and quantify up to 99% of human XFLC. The clinical utility of the assay includes early detection in individuals suspected of having plasma cell disorders (MGUS, SMM, MM, IgM-AL and AL), differentiation from other amyloidosis such as ATTR, use in companion diagnosis, proving of target conjugation, assessment of treatment response, detection of MRD, detection of recurrence. Assays, such as MSD, lateral flow, mass spectrometry, are also implemented that quantify the resulting dLCCD biomarkers and / or can further increase assay sensitivity.
Owner:PROTEGO BIOPHARMA INC

A primer probe combination and kit for detecting liver cancer gene methylation

The present invention provides a primer-probe combination and a kit for detecting methylation of liver cancer genes, wherein the primer-probe combination includes at least one of the following groups of biomarkers as primer sequences corresponding to methylation markers, and the methylation markers are composed of methylated nucleotide sequences in a target region of ACP1 gene, BMPR1A gene, PLAC8 gene or RNF135 gene. The present invention screens and diagnoses liver cancer by automatically detecting gene methylation rates from peripheral blood; it has the following specific advantages: ① taking peripheral blood samples, non-invasive automated testing, not relying on professional doctors, high repeatability, and objective results; ② the gene methylation markers that are highly correlated with liver cancer are screened, and digital PCR detection with high analytical sensitivity is used for detection, which has better clinical accuracy; ③ high-throughput detection, suitable for large sample inspection.
Owner:湖南宏雅基因技术有限公司

Assays for lysosomal storage diseases

The disclosure provides the methods of detecting an anti-lysosomal enzyme antibody in a human subject (e.g., in the presence of a circulating lysosomal enzyme) and the methods of improving an efficacy of an anti-lysosomal enzyme antibody assay (e.g., improving the assay sensitivity and the circulating lysosomal enzyme tolerance), comprising pre-treating the biological sample of the subject with a base at pH of about 11 or greater and measuring the presence of the anti-lysosomal enzyme antibody in the biological sample of the subject.
Owner:SANGAMO THERAPEUTICS INC

Methods and systems for rapid detection of microorganisms using recombinant infectious factors to express indicator subunits

Disclosed herein are methods and systems for rapid detection of microorganisms, such as bacteria, in a sample. Also disclosed is a genetically modified bacteriophage comprising an indicator gene encoding one subunit of an indicator protein. The specificity of the bacteriophage allows detection of specific target bacteria, and the indicator signal can be amplified to optimize assay sensitivity.
Owner:LABORATORY CORPORATION OF AMERICA HOLDINGS INC

Selecting low technical noise biomarkers for sensitive molecular diagnostics

Described herein are methods for the detection of molecular residual disease (MRD) and cancer by analysis of cell‑free nucleic acids. The invention provides a capture panel comprising target‑specific probes that are directed to one or more genomic regions encompassing a spectrum of variant types, namely structural variants (SV), large insertions / deletions, phased single‑nucleotide variants, small insertions / deletions, multi‑nucleotide variants and single‑nucleotide variants. By contacting a nucleic‑acid sample derived from a subject with the probe panel, the method enriches variant‑bearing molecules and subjects the captured set to sequencing. Disease presence or the likelihood thereof is determined on the basis of each target region, optionally integrating epigenetic information (e.g., differential methylation) obtained from a tumour biopsy. The probe design is adapted to technical noise, allocating higher probe concentrations to low‑noise, high‑complexity variants, thereby reducing reliance on molecular barcodes, lowering required read depth and improving analytical sensitivity for both fixed‑panel and patient‑specific MRD assays.
Owner:GUARDANT HEALTH INC

Methods and Systems for the Rapid Detection of Microorganisms Using Recombinant Infectious Agents to Express an Indicator Subunit

Disclosed herein are methods and systems for rapid detection of microorganisms such as bacteria in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene encoding one subunit of an indicator protein. The specificity of the bacteriophage allows detection of a particular bacteria of interest and an indicator signal may be amplified to optimize assay sensitivity.
Owner:LABORATORY CORPORATION OF AMERICA HOLDINGS INC

Detection method of intermediate 3-(1-piperazinyl)-1, 2-benzisothiazole hydrochloride for ziprasidone synthesis

ActiveCN119064497AReduce post-processing costseasy to separateComponent separationKetone synthesisAssay sensitivity
The invention provides a method for detecting an intermediate 3-(1-piperazinyl)-1, 2-benzisothiazole hydrochloride for ziprasidone synthesis, and belongs to the technical field of drug quality analysis and detection.The method comprises the steps that acetonitrile and a triethylamine-containing aqueous solution in a certain proportion are selected as mobile phases, program gradient elution is cooperatively carried out, and the separation degree and analysis sensitivity are improved; according to the method, a diode array detector is adopted, 2008-2022 Shimadzu Corporation LabSolutions software / similar software carried by the diode array detector is used for confirming the relative quantification of the main impurities in the main product 3-(1-piperazinyl)-1, 2-benzisothiazole hydrochloride, and the method provided by the invention is short in analysis time, simple in analysis operation and relatively good in repeatability and adaptability.
Owner:JIANGXI KAIYUAN BIOMEDICAL TECH CO LTD

Electrochemiluminescence immunosensor for detecting tumor marker and application thereof

ActiveCN114113046BAntigenGraphite carbon
The application belongs to the technical field of electrochemiluminescence immunosensor, discloses a kind of electrochemiluminescence immunosensor for detecting tumor marker and application thereof, and the preparation system of electrochemiluminescence immunosensor for detecting tumor marker includes: graphite carbon nitride preparation module, working electrode pretreatment module, central control module, antigen standard solution preparation module, modified electrode preparation module, immunosensor preparation module, tumor marker detection module, sensor detection curve drawing module, data storage module, update display module.The electrochemiluminescence immunosensor for detecting tumor marker provided by the application has high analysis sensitivity, strong specificity, is simple to use and low in cost.The application improves the sensitivity of electrochemiluminescence immunosensor by dropping coating bovine serum albumin solution and tumor marker antigen standard solution on the surface of graphite carbon nitride working electrode, and greatly simplifies the electrode preparation process without enzyme and label.
Owner:GUANGDONG MEDICAL UNIV

Single nanoparticle technology enhanced DNA molecular machine for miRNA sensitive detection

The DNA molecular machine makes a major breakthrough in the fields of biosensing, bioimaging, early cancer diagnosis and the like. However, the current DNA molecular machine strategy is continuously challenged by insufficient analysis sensitivity, and a precise signal amplification program is often essential. Single-particle inductively coupled plasma mass spectrometry (SP-ICPMS) has excellent sensitivity, and background noise and detection signals can be effectively distinguished. In the research, a novel method is provided, and a 3D DNA molecular machine is constructed by using single nanoparticle counting and bispecific nuclease (DSN) assisted signal amplification and is used for detecting the invasive prostate cancer (PCa) biomarker miRNA-200c. The strategy is improved in sensitivity, the limit of detection (LOD) is 0.93 pM (28 amol), and the strategy is successfully applied to human serum sample analysis.
Owner:SICHUAN UNIV

Detection method of ziprasidone synthesis intermediate 3-(1-piperazine)-1,2-benzisothiazole hydrochloride

ActiveCN119064497BReduce post-processing costseasy to separateKetone synthesisAssay sensitivity
The invention provides a detection method for ziprasidone synthesis intermediate 3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride, belonging to the technical field of drug quality analysis and detection. The invention selects acetonitrile and triethylamine-containing aqueous solution in a certain proportion as mobile phases, performs programmed gradient elution in coordination, and improves separation degree and analytical sensitivity; a diode array detector is adopted, and the 2008-2022Shimadzu Corporation LabSolutions software / similar software carried by the diode array detector is used to confirm the relative quantification of main impurities in the main product 3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride; and the method provided by the invention has short analysis time, simple analysis operation and good repeatability and adaptability.
Owner:JIANGXI KAIYUAN BIOMEDICAL TECH CO LTD

Assays for lysosomal storage diseases

The disclosure provides the methods of detecting an anti-lysosomal enzyme antibody in a human subject (e.g., in the presence of a circulating lysosomal enzyme) and the methods of improving an efficacy of an anti-lysosomal enzyme antibody assay (e.g., improving the assay sensitivity and the circulating lysosomal enzyme tolerance), comprising pre-treating the biological sample of the subject with a base at pH of about 11 or greater and measuring the presence of the anti-lysosomal enzyme antibody in the biological sample of the subject.
Owner:SANGAMO THERAPEUTICS INC

Blood detection equipment performance evaluation method and system based on big data

The invention relates to the technical field of equipment performance evaluation, in particular to a blood detection equipment performance evaluation method and system based on big data, and the method comprises the steps: collecting real sample detection data of detection equipment in a preset time period; determining an upper critical region and a lower critical region, and establishing a critical sample database; calculating a critical resolution index based on the critical sample database, wherein the critical resolution index is obtained through weighted calculation of a critical precision index, a boundary separation index and a distribution continuity index; grouping the critical sample database according to matrix types, calculating critical resolution indexes, and comparing, analyzing, identifying and analyzing sensitivity differences; setting a sliding time window, obtaining critical resolution indexes of different time periods, obtaining an analysis sensitivity time sequence, carrying out trend analysis, outputting a performance degradation curve, and triggering performance degradation early warning; and fusing the critical resolution index, analyzing the sensitivity difference and the performance degradation curve, and outputting an equipment performance evaluation report.
Owner:NANJING HUAYIN MEDICAL LAB CO LTD

Copper growth enhanced plasma assay for separation-free exosome analysis

An assay for detecting target extracellular vesicles in a sample effectively utilizes a copper shell grown on a gold nanostructure labeling the target extracellular vesicles to enhance a scattered signal, thereby improving assay sensitivity.
Owner:杜兰教育基金管理委员会

Synchronous determination method for multiple endocrine disrupters in solid waste

PendingCN119619330Aeffective monitoringEasy and quick pre-processing stepsComponent separationPerturbateurs endocriniensFluid phase
The invention discloses a method for synchronously measuring multiple endocrine disruptors in solid waste. The method comprises the following steps: collecting a solid waste sample, and refrigerating and storing the solid waste sample by adopting a colored sealed container; performing first vortex treatment on the solid waste sample by adopting a vortex reagent to obtain a to-be-extracted sample; performing ultrasonic extraction treatment on the to-be-extracted sample according to a first extraction condition to obtain a primary extraction product; determining a final object to be detected according to the turbidity condition of the primarily extracted product; setting chromatographic conditions and mass spectrum conditions, and performing HPLC-MS / MS measurement on the final to-be-measured substance based on the chromatographic conditions and the mass spectrum conditions to obtain content data of the 16 ED Cs in the solid waste sample; according to the method, ultrasonic extraction is combined with a high performance liquid chromatography-tandem mass spectrometry technology, related conditions are optimized, simple, convenient and rapid pretreatment steps are realized, and the analysis sensitivity, the recovery rate and the precision are improved.
Owner:江苏康达检测技术股份有限公司